Low Prevalence of Hypercalcemia in Korean Dialysis Patients: Possible Role of Dietary Phosphate Intake

Abstract

Get full access to this article

View all access options for this article.

References

Hercz

, Coburn

J.W.

Prevention of phosphate retention and hyperphosphatemia in uremia.

Kidney Int 1987; 32(Suppl 22): S215–20.

Khanna

, Nolph

K.D.

, Oreopoulos

D.G.

Renal osteodystrophy. The essentials of peritoneal dialysis. Dordrecht: Kluwer Academic, 1993.

Llach

, Bover

Renal osteodystrophy. In: Brenner

B.M.

, ed. The Kidney. Philadelphia: WB Saunders, 1995: 2187–230.

Slatopolsky

, Weerts

, Lopez-Hilker

, Norwood

, Zink

, Windus

Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis.

N Engl J Med 1986; 315: 157–61.

Raman

, Chong

Y.K.

, Sreenevasan

G.A.

Effects of varying dialysate calcium concentrations on the plasma calcium fractions in patients on dialysis.

Nephron 1976; 16: 181–5.

Gonella

, Calebrese

, Vagelli

, Pratesi

, Lamon

, Talario

Effects of high CaCO₃ supplements on serum calcium and phosphorus in patients on regular hemodialysis treatment.

Clin Nephrol 1985; 24: 147–50.

Mactier

R.A.

, van Stone

, Cox

, van Stone

, Twardowski

Calcium carbonate is an effective phosphate binder when dialysate calcium concentration is adjusted to control hypercalcemia.

Clin Nephrol 1987; 28: 222–6.

Stein

, Yudies

M.Y.

, Sirota

R.A.

Calcium carbonate as a phosphate binder.

N Engl J Med 1987; 316: 109–10.

Cunningham

, Coldwell

R.D.

, Noonan

, Sawyer

, Makin

H.L.

Dialysate calcium reduction in CAPD patients treated with calcium carbonate and alfacalcitriol.

Nephrol Dial Transplant 1992; 7: 63–8.

10.

Weinreich

, Passlick-Deetjen

, Ritz

Low dialysate calcium in continuous ambulatory peritoneal dialysis: A randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.

Am J Kidney Dis 1995; 25: 452–60.

11.

Fournier

, Morniere

, Sebert

J.L.

, Dkhissi

, Atik

, Leflon

Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremia.

Kidney Int 1986; 29(Suppl 18): S114–19.

12.

Brown

C.B.

, Hamdy

N.A.T.

, Boletis

, Kanis

J.A.

Rationale for the use of low calcium solution in CAPD. In: Peritoneal dialysis. Milan: Wichtig Editore, 1991: 125–37.

13.

Hokanen

, Kala

, Grohagen-Riska

, Ikaheimo

CAPD with low calcium dialysate and calcium carbonate results of a 24-week study. In: Khanna

, Nolph

K.D.

, Prowant

B.F.

, Twardowski

Z.J.

, Oreopoulos

D.G.

, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin, 1992; 8: 356–61.

14.

Hodsman

A.B.

, Cordy

P.E.

, Fraher

L.J.

Parathyroid hormone, vitamin D, and metabolic bone disease in dialysis patients. In: Nissenson

A.R.

, Fine

R.N.

, Gentile

D.E.

, eds. Clinical dialysis. Connecticut: Appleton & Lange, 1990: 494–534.

15.

Rippe

, Levin

Should dialysis calcium be varied in proportion to the amount of ultrafiltration in peritoneal dialysis dwell? Directions from a computer simulation.

Perit Dial Int 1998; 18: 474–7.

16.

Tchai

B.S.

The trends and prospects of Korean dietary intakes.

Korean J Nutr 1990; 23: 187–96.

17.

Sung

C.J.

, Choi

M.K.

, Jo

J.H.

, Lee

J.Y.

Relationship among dietary intake, blood level, and urinary excretion of minerals and blood pressure in Korean rural adult men and women.

Korean J Nutr 1993; 26: 89–97.